BRIEF published on 11/07/2024 at 22:15, 13 days 15 hours ago GENFIT publie ses résultats financiers du troisième trimestre 2024 Croissance Des Revenus Traitement De La CBP Chiffres Financiers De GENFIT Situation De Trésorerie 2024 Collaboration Ipsen
BRIEF published on 11/07/2024 at 22:15, 13 days 15 hours ago GENFIT Reports Third Quarter 2024 Financial Update Revenue Growth PBC Treatment GENFIT Financials Cash Position 2024 Ipsen Collaboration
PRESS RELEASE published on 11/07/2024 at 22:10, 13 days 15 hours ago GENFIT Reports Third Quarter 2024 Financial Information GENFIT reports €59.7M revenue for Q3 2024 with €96.0M cash. Focus on liver diseases. Results surpass 2023 Revenue Cash Position Q3 2024 Liver Diseases GENFIT
PRESS RELEASE published on 09/19/2024 at 22:10, 2 months 1 day ago GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société
PRESS RELEASE published on 09/19/2024 at 22:10, 2 months 1 day ago GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update
PRESS RELEASE published on 09/19/2024 at 18:52, 2 months 1 day ago Rapport d'activité et financier semestriel 2024 - Rapport des Commissaires aux Comptes
PRESS RELEASE published on 09/19/2024 at 18:46, 2 months 1 day ago Rapport d'activité et financier semestriel 2024 - Attestation du Responsable
PRESS RELEASE published on 09/19/2024 at 18:40, 2 months 1 day ago Rapport d'activité et financier semestriel 2024
BRIEF published on 07/26/2024 at 13:50, 3 months 25 days ago GENFIT : Avis positif du comité de l'EMA pour Iqirvo® d'Ipsen dans la cholangite biliaire primitive GENFIT EMA Iqirvo® Elafibranor Traitement De La CBP
BRIEF published on 07/26/2024 at 13:50, 3 months 25 days ago GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® in Primary Biliary Cholangitis GENFIT EMA Iqirvo® Elafibranor PBC Treatment
Published on 11/21/2024 at 13:00, 23 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 23 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 23 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 23 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 23 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 48 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 8 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 25 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 25 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 25 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 17 hours 16 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 18 hours 3 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
